Recent Quotes
My Watchlist
Indicators
Investor Uprising 25
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

111.66 +0.96 (+0.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,274,470
Open 111.73
Bid (Size) 110.70 (3)
Ask (Size) 111.44 (3)
Prev. Close 110.70
Today's Range 110.04 - 112.16
52wk Range 74.75 - 142.00
Shares Outstanding 96,748,901
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a... 
Via Benzinga
NASDAQ:DXCM: a strong growth stock preparing for the next leg up?.
DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?. 
Via Chartmill

Performance

YTD
-9.29%
-9.29%
1 Month
-3.80%
-3.80%
3 Month
-14.57%
-14.57%
6 Month
-12.28%
-12.28%
1 Year
-14.54%
-14.54%

More News

Read More
2 Healthcare Stocks to Buy at a Discount
Via The Motley Fool
What Analysts Are Saying About DexCom Stock
Via Benzinga
Top 4 Must-Have Healthcare Stocks for Long-Term Growth
Via MarketBeat
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
Why NASDAQ:DXCM Is a Standout High-Growth Stock in a Consolidation Phase.
Via Chartmill
Here's How Much $1000 Invested In DexCom 5 Years Ago Would Be Worth Today
Via Benzinga
3 Breakthrough Medical Device Stocks to Invest In Now
Via InvestorPlace
2 Top Growth Stocks to Buy With $1,000
Via The Motley Fool
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034
Via InvestorPlace
Peering Into DexCom's Recent Short Interest
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,800 Today
Via Benzinga
Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey
Via InvestorPlace
Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
From DexCom, Inc.
Via Business Wire
The 3 Best Diabetes Stocks to Buy in June 2024
Via InvestorPlace
What's New In the Consumer Tech World Last Week? News That You Should Know (June 9-June 15, 2024)
Via Benzinga
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Via Investor's Business Daily
Exposures Product Safety
Apple Watch Now Directly Syncs With Dexcom's G7 Glucose Monitor
Via Benzinga
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
From DexCom, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
From Dexcom, Inc.
Via Business Wire
Bull Market Buys: 2 Growth Stocks to Own for the Long Haul
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.